With the support of Lyon Ingénierie Projet and EZUS Lyon, the subsidiaries of Université Claude Bernard Lyon 1, this new service-oriented spin-off proposes new innovative technological offers and a wider range of R&D services in the field of Indoor Air Quality (IAQ).

VirexpR is specialized in the generation of atmospheres contaminated by viruses and complex mixtures of infectious pathogens in test benches dedicated to the experimental evaluation of air treatment and analysis technologies and devices. An offer of in situ sampling and analysis of indoor air is also offered by VirexpR for a large panel of respiratory pathogenic viruses, such as influenza viruses, pneumoviruses, rhinoviruses, adenoviruses and coronaviruses, including different SARS-CoV-2 variants.

In synergy with several of its providers and industrial partners in the Auvergne-Rhône-Alpes region, VirexpR will mobilize its expertise, technologies, and logistics in BSL-2 and BSL-3 facilities within the Lyonbiopole innovation center. This offer is at the service of establishments open to the public (ERP), communities and manufacturers, in order to contribute to better control of respiratory viral pathogens and more generally to better indoor air quality, with major health, economic and societal implications and challenges.